
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.(COGT)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
cogt · 股价预测 · 12 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 12 位华尔街分析师
Buy
12 位分析师
共识
评级分布
12 个月目标价
High
$60.00
Consensus
$49.40
+58.8% upside
Low
$35.00
Median: $52 · Last Close: $31.11
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$49.40
58.8% upside
High Target
$60
92.9%
Low Target
$35
12.5%
Current Price
$31.11
as of today
Based on analyst price targets, the COGT stock price prediction for the next 12 months ranges from $35 to $60. The consensus COGT price forecast of $49.40 implies 58.8% upside from the current price of $31.11.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $30.31 | ↓ 2.55% |
1-day model range: $30.17–$30.45. Peak: $30.45 (-2.55%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · COGT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-29 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-17 | Wedbush | Maintains | Outperform→Outperform |
| 2026-02-18 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-01-21 | Wedbush | Maintains | Outperform→Outperform |
| 2026-01-06 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-19 | JP Morgan | Maintains | Overweight→Overweight |
| 2025-12-08 | Needham | Maintains | Hold→Hold |
| 2025-11-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-11 | Baird | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Cogent Biosciences, Inc. (COGT) stock. Of the recent 84 rating actions, 0 were upgrades and 3 were downgrades. 12 analysts currently cover COGT.
分析师推荐趋势
COGT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 2 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$11M
↓ 98.5% YoY
Revenue Next Year
$345M
↑ 3083.3% YoY
EPS This Year
$-2.25
EPS Next Year
$-0.78
↓ 65.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast COGT EPS of $-2.25 for the current fiscal year, based on estimates from 9 analysts. The COGT revenue forecast is $11M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
COGT 股价预测由两类独立数据源支撑:来自 12 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。COGT 的共识目标价为 $49.40(+58.8% 上行空间),分析师共识为 Buy。
COGT 的短期预测(明日)为 $30.31(-2.55%)。
Cogent Biosciences, Inc. 在 NASDAQ 上市,代码 COGT。COGT 在 2027 年的整体展望偏积极,在覆盖分析师中约 83% 对应 Buy 共识。
常见问题
COGT 预测 · 8 个问题根据 12 位华尔街分析师,COGT 的 12 个月平均目标价为 $49.40,最高 $60.00、最低 $35.00。若有图表,中位目标价可在上方查看。相对当前价 $31.11,隐含约 +58.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.